Ralph Charlton
Chief Tech/Sci/R&D Officer bij SPRUCE BIOSCIENCES, INC.
Vermogen: 43 523 $ op 31-03-2024
Profiel
Ralph William Charlton is currently the Chief Medical Officer at Spruce Biosciences, Inc. Prior to this, he worked as the Executive Medical Director at Allergan, Inc. from 2018 to 2019, Senior Medical Director-Clinical Development at Ascendis Pharma, Inc. from 2019 to 2020, and Vice President-Clinical Development at 89bio, Inc. from 2020 to 2022.
Charlton earned a doctorate degree from the University of Southern California.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SPRUCE BIOSCIENCES, INC.
0.13% | 25-03-2024 | 55 373 ( 0.13% ) | 43 523 $ | 31-03-2024 |
Actieve functies van Ralph Charlton
| Bedrijven | Functie | Begin |
|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 14-03-2022 |
Eerdere bekende functies van Ralph Charlton
| Bedrijven | Functie | Einde |
|---|---|---|
| 89BIO, INC. | Chief Tech/Sci/R&D Officer | 01-02-2022 |
| Ascendis Pharma, Inc. | Chief Tech/Sci/R&D Officer | 01-11-2020 |
| ALLERGAN, INC. | Chief Tech/Sci/R&D Officer | 01-05-2019 |
Opleiding van Ralph Charlton
| University of Southern California | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SPRUCE BIOSCIENCES, INC. | Health Technology |
| 89BIO, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
| Ascendis Pharma, Inc. |
